Allergy immunotherapy discussions require a careful match between symptoms, exposure, sensitisation, product composition, patient goals, and clinical suitability. Molecular allergology may add useful context by clarifying which components appear to be driving the sensitisation pattern.
Interpretation questions before immunotherapy
- Does the molecular profile support genuine sensitisation to the clinically relevant source?
- Are major allergen components present?
- Is the pattern dominated by cross-reactive panallergens?
- Do symptoms match exposure timing, seasonality, and environment?
- Would specialist review or additional testing change the interpretation?
For example, a patient with symptoms during a relevant pollen season and sensitisation to major pollen components may raise a different interpretation question from a patient whose pattern is dominated by broadly cross-reactive markers. The molecular profile does not decide treatment by itself, but it can sharpen the questions asked during specialist review.
Questions molecular profiles may support
Is the sensitisation pattern consistent with the suspected allergen source? Are major components present? Is the pattern dominated by cross-reactive molecules? Does the result align with the seasonality, exposure, and symptom profile?
Examples of useful contexts
In pollen allergy, molecular profiles may help distinguish major pollen sensitisation from panallergen-driven positivity. In venom allergy, marker allergens may help clarify species-specific sensitisation where whole venom tests are double-positive. In mite or animal allergy, molecular profiles can support discussion of whether the pattern fits exposure and symptoms.
Education focus
MAA education should avoid presenting molecular testing as a shortcut to treatment selection. The more useful goal is to teach clinicians how molecular information fits into a broader clinical assessment.
Teaching point
Molecular profiles can support immunotherapy conversations when they are interpreted in context, with clear recognition of limitations and local clinical guidance.
